Portola Pharmaceuticals Obtains $121,800,000 New Funding

  • Feed Type
  • Date
    5/22/2013
  • Company Name
    Portola Pharmaceuticals
  • Mailing Address
    270 E. Grand Avenue South San Francisco, CA 94080
  • Company Description
    Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) is a biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapeutics for acute and chronic cardiovascular and vascular disease. Portola has two drug candidates in clinical development.
  • Website
    http://www.portola.com
  • Transaction Type
    IPO
  • Transaction Amount
    $121,800,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms